Cancer Genetics, Inc.

218 articles about Cancer Genetics, Inc.

• Cancer Genetics To Report Biomarker Findings In Metastatic Clear Cell Renal Carcinoma Using A CGI-Designed NGS Panel At The 14th International Kidney Cancer Symposium In Miami, FL

  11/9/2015

• Cancer Genetics Further Expands The Availability Of Genomic Testing As It Signs In-Network Provider Agreements With Blue Cross Blue Shield Of North Carolina, Blue Cross Blue Shield Nebraska, And Wellmark

  11/9/2015

• Cancer Genetics Prices Public Offering Of Securities

  11/6/2015

• Cancer Genetics To Report Third Quarter Financial Results On Tuesday, November 10, 2015

  11/4/2015

• Cancer Genetics Receives Third Patent For Proprietary Genomic FHACT Test, Further Advancing The Detection And Treatment Of Cervical And Other HPV-Associated Cancers

  10/28/2015

• Cancer Genetics Finalizes Purchase Of Los Angeles-Based Molecular Profiling Laboratory, Response Genetics, Adding $10-$12M In Annual Revenue And Establishing A National Clinical Sales Footprint

  10/12/2015

• Cancer Genetics Receives Bankruptcy Court Approval To Purchase Los Angeles-Based Response Genetics

  10/2/2015

• Cancer Genetics To Report Results From Two Independent Studies At The 30th International Papillomavirus Conference & Clinical And Public Health Workshops (HPV 2015)

  9/17/2015

• Cancer Genetics Increases Access To Proprietary Diagnostics Tests As Part Of New Agreement With Blue Cross Blue Shield Of Illinois

  9/8/2015

• Cancer Genetics To Present At The Sidoti Emerging Growth Conference On September 2, 2015

  9/2/2015

• RedChip Issues Research Update On Cancer Genetics

  8/13/2015

• Cancer Genetics Announces Strong Second Quarter 2015 Results

  8/11/2015

• Response Genetics Files for Chapter 11, Snapped Up By Cancer Genetics

  8/10/2015

• Cancer Genetics, Inc. To Report Second Quarter Financial Results On Tuesday, August 11

  8/4/2015

• Cancer Genetics, Inc. To Present A Unique, Comprehensive NGS-Based Lymphoma Panel At Cancer Genomics Consortium And Cytogenomics Array Group Meeting

  8/3/2015

• Cancer Genetics, Inc. Announced Today That It Has Suspended Its Activity On The "At-The-Market" Equity Offering

  7/24/2015

• Cancer Genetics, Inc. Announces The Expansion Of Access To Its Proprietary Diagnostic Tests Through Agreement With Harvard Pilgrim Healthcare

  7/16/2015

• Cancer Genetics, Inc. Appoints Rita Shaknovich, M.D., Ph.D., As Group Medical Director And Vice President Of Hematopathology Service

  7/9/2015

• Cancer Genetics, Inc. Announces A Partnership With ICON's Laboratory Services To Offer Comprehensive Oncology Laboratory Testing And Solutions

  7/7/2015

• Cancer Genetics, Inc. Awarded Largest Clinical Trial In Company History; Will Provide Comprehensive Testing For Global, Multi-Year, Multi-Center Clinical Trial In Chronic Lymphocytic Leukemia (CLL)

  6/30/2015